Streetbeat News

Products Services

HSAI

Hesai Technology (NASDAQ:HSAI) has announced a new design win with FAW Group, one of the largest automotive OEMs in China, for their next generation EV model under Hongqi brand. This marks the first design win for Hesai's ultra-thin long-range lidar ET25, and the first series production program with an in-cabin lidar solution to be announced globally. The program is expected to begin mass production and delivery by the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 2:16 pm

AVGO

GOOG

GOOGL

NVDA

Nvidia Corp's stock is trading higher despite U.S. Chips Act policies against China and competition from Huawei's Kirin 9000s processor. China, including Hong Kong, accounted for over 20% of Nvidia's sales in its latest financial year, while Taiwan represented more than 25%. Meanwhile, Alphabet Inc's Google denied reports of replacing Broadcom Inc as a supplier of artificial intelligence chips.

Portfolio Pulse from Anusuya Lahiri

September 22, 2023 | 2:15 pm

GOOG

GOOGL

MS

MSFT

Morgan Stanley's new AI tool, AI @ Morgan Stanley Assistant, designed to aid financial advisers, has faced criticism for its lack of accuracy and responsiveness. Comparisons have been drawn with other AI tools like Microsoft's OpenAI's ChatGPT and Google's Bard, with Morgan Stanley's offering seemingly falling short. Some insiders have labeled the initiative as a publicity stunt, while others have criticized the bank for rebranding existing tools under the AI banner.

Portfolio Pulse from Anusuya Lahiri

September 22, 2023 | 2:10 pm

PSNY

Polestar, a Swedish electric vehicle manufacturer, has opened a new retail location in North Carolina, marking its debut in the Carolinas. The new location is part of the brand's expansion in the American Southeast. The company has seen a significant shift in the automotive market, with many people choosing to drive electric. All 31 Polestar Spaces in North America now feature Polestar 3 SUV display prototypes in their showrooms. The Polestar 3 is available to order now with deliveries set to begin in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:46 pm

META

Citi has released a note indicating that Meta Platforms' Reels ad loads have increased to 19% quarter-to-date (QTD) from 17% in Q2. This is attributed to newer ad units, greater advertiser demand, and an improving online advertising environment.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:44 pm

MLGO

MicroAlgo Inc. (NASDAQ:MLGO) shares surged after the company unveiled a knowledge-enhanced backtracking search algorithm designed to boost the performance and efficiency of research institutions. The algorithm is expected to be used across various sectors, including healthcare, energy, transportation, and retail. MLGO shares are trading higher by 38.2% to $5.59.

Portfolio Pulse from Nabaparna Bhattacharya

September 22, 2023 | 1:39 pm

SGEN

Seagen announced that its PADCEV and KEYTRUDA drugs significantly improved overall survival and progression-free survival in patients with previously untreated advanced bladder cancer in a pivotal Phase 3 EV-302 trial. This news has led to a rise in Seagen's share price.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:21 pm

THAR

Hillstream BioPharma is planning to acquire a clinical stage asset and has announced a corporate name change to Tharimmune. The company's stock will trade on Nasdaq under the ticker 'THAR' effective from September 25, 2023. Tharimmune also expects to launch and complete a Phase 1 trial in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:06 pm

B

Barnes Aerospace has announced two extended long-term agreements with Safran. The agreements include extending their relationship with Safran Aircraft Engines on aftermarket services for LEAP casings and extending the CFM56 component repair agreement.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:02 pm

COYA

Coya Therapeutics, Inc. (NASDAQ:COYA) has licensed exclusive worldwide rights to a proprietary Exosome Engineering Technology from Carnegie Mellon University. The technology allows for the engineering of exosomes, which can be used as drug delivery vehicles. The technology overcomes previous limitations of exosome manipulation and does not require genetic modifications. It also allows for the tethering of proteins of interest to the exosome surface and loading cargo within the exosome interior. The technology has potential applications in neurodegenerative, autoimmune, and oncologic diseases.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 1:01 pm